Reduced plasma phosphatidylethanolamines in e‐cigarette, or vaping, product use‐associated lung injury (EVALI)-Reference-Cited by-同舟云学术

Reduced plasma phosphatidylethanolamines in e‐cigarette, or vaping, product use‐associated lung injury (EVALI)

Author:

McGraw Matthew D.¹²^ORCID,Croft Daniel P.³^ORCID,Nacca Nicholas E.⁴^ORCID,Rahman Irfan²^ORCID

Affiliation:

1. Department of Pediatrics, Division of Pediatric Pulmonology University of Rochester Medical Center Rochester New York USA

2. Department of Environmental Medicine University of Rochester Medical Center Rochester New York USA

3. Department of Medicine, Division of Pulmonary Critical Care University of Rochester Medical Center Rochester New York USA

4. Department of Toxicology University of Rochester Medical Center Rochester New York USA

Funder

National Center for Advancing Translational Sciences

National Heart, Lung, and Blood Institute

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

Reference9 articles.

1. Center for Disease Control & Office on Smoking and Health. Outbreak of Lung Injury Associated with the Use of E‐Cigarette or Vaping Products;2021.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaping: Public Health, Social Media, and Toxicity;Online Journal of Public Health Informatics;2024-04-11

5. E-cigarettes and vaping;Reference Module in Biomedical Sciences;2023